Variation in immunoglobulin use and impact on survival in myeloma
Chai, Khai Li, Wellard, Cameron, Thao, LTP, Aoki, Naomi, Moore, Elizabeth M, Augustson, Bradley M, Bapat, Akshay, Blacklock, Hilary, Chng, Wee J, Cooke, Rachel, Forsyth, Cecily J, Goh, Yeow‐Tee, Hamad, Nada, Harrison, Simon J, Ho, P Joy, Hocking, Jay, Kerridge, Ian, Kim, Jin Seok, Kim, Kihyun, King, Tracy, McCaughan, Georgia J, Mollee, Peter, Morrissey, C Orla, Murphy, Nick, Quach, Hang, Tan, Xuan Ni, Tso, Allison CY, Wong, Kimberly SQ, Yoon, Sung‐Soo, Spencer, Andrew, Wood, Erica M, McQuilten, Zoe K
Published in EJHaem (01.08.2024)
Published in EJHaem (01.08.2024)
Get full text
Journal Article
Hereditary haemorrhagic telangiectasia
Mangkorntongsakul, Varitsara, Forsyth, Cecily J
Published in Medical journal of Australia (01.01.2019)
Published in Medical journal of Australia (01.01.2019)
Get more information
Journal Article
Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment‐free and overall survival in Chronic Lymphocytic Leukaemia
Crassini, Kyle R., Zhang, Eva, Balendran, Shalini, Freeman, Jane A., Best, O. Giles, Forsyth, Cecily J., Mackinlay, Naomi J., Han, Ping, Stevenson, William S., Mulligan, Stephen P.
Published in British journal of haematology (01.04.2018)
Published in British journal of haematology (01.04.2018)
Get full text
Journal Article
Paraprotein associated heparin resistance during cardiopulmonary bypass
Khuong, Jacqueline N, Forsyth, Cecily J, Manuel, Lucy, Kingsford-Smith, Kate, Srivastava, Arpit, Bassin, Levi
Published in Perfusion (01.09.2023)
Published in Perfusion (01.09.2023)
Get more information
Journal Article
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets
Yeung, David T., Osborn, Michael P., White, Deborah L., Branford, Susan, Braley, Jodi, Herschtal, Alan, Kornhauser, Michael, Issa, Samar, Hiwase, Devendra K., Hertzberg, Mark, Schwarer, Anthony P., Filshie, Robin, Arthur, Christopher K., Kwan, Yiu Lam, Trotman, Judith, Forsyth, Cecily J., Taper, John, Ross, David M., Beresford, Jennifer, Tam, Constantine, Mills, Anthony K., Grigg, Andrew P., Hughes, Timothy P.
Published in Blood (05.02.2015)
Published in Blood (05.02.2015)
Get full text
Journal Article
Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia
Freeman, Jane A., Crassini, Kyle R., Best, O. Giles, Forsyth, Cecily J., Mackinlay, Naomi J., Han, Ping, Stevenson, William, Mulligan, Stephen P.
Published in Leukemia & lymphoma (01.01.2013)
Published in Leukemia & lymphoma (01.01.2013)
Get full text
Journal Article
Recommendations for the use of pegylated interferon‐α in the treatment of classical myeloproliferative neoplasms
Forsyth, Cecily J., Chan, Wai‐Hoong, Grigg, Andrew P., Cook, Nathalie C., Lane, Steven W., Burbury, Kate L., Perkins, Andrew C., Ross, David M.
Published in Internal medicine journal (01.08.2019)
Published in Internal medicine journal (01.08.2019)
Get full text
Journal Article
A Multicenter, Open-Label, Noncomparative Screening Study of Enzastaurin in Adult Patients With Non-Hodgkin Lymphomas
Forsyth, Cecily J, Gomez-Almaguer, David, Camargo, Johnny F.C, Eliadis, Paul E, Crespo-Solis, Erick, Pereira, Juliana, Gutierrez-Aguirre, Cesar H, Rivas-Vera, Silvia, Roberson, Stephanie, Lin, Boris, Smith, Neil V, Hamid, Oday
Published in Clinical lymphoma, myeloma and leukemia (01.08.2013)
Published in Clinical lymphoma, myeloma and leukemia (01.08.2013)
Get full text
Journal Article
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line RUNX1, GATA2, and DDX41 variants
Homan, Claire C, Drazer, Michael W, Yu, Kai, Lawrence, David Michael, Feng, Jinghua, Arriola-Martinez, Luis Alberto, Pozsgai, Matthew J, McNeely, Kelsey E, Ha, Thuong Thi, Venugopal, Parvathy, Arts, Peer, King-Smith, Sarah, Cheah, Jesse Jc, Armstrong, Mark, Wang, Paul, Bödör, Csaba, Cantor, Alan B, Cazzola, Mario, Degelman, Erin S, DiNardo, Courtney D, Duployez, Nicolas, Favier, Rémi, Fröhling, Stefan, Rio-Machin, Ana, Klco, Jeffery M, Krämer, Alwin, Kurokawa, Mineo, Lee, Joanne, Malcovati, Luca, Morgan, Neil V, Georges, Natsoulis, Owen, Carolyn, Patel, Keyur P, Preudhomme, Claude, Raslova, Hana, Rienhoff, Hugh Young, Ripperger, Tim, Schulte, Rachael R, Tawana, Kiran, Velloso, Elvira, Benedict, Yan, Kim, Erika Mijin Kwon, Sood, Raman, Hsu, Amy P, Holland, Steven M, Phillips, Kerry, Poplawski, Nicola, Babic, Milena, Wei, Andrew H, Forsyth, Cecily J, Mar Fan, Helen, Lewis, Ian, Cooney, Julian P, Susman, Rachel, Fox, Lucy C, Blombery, Piers, Singhal, Deepak, Hiwase, Devendra K, Phipson, Belinda, Schreiber, Andreas W, Hahn, Christopher N, Scott, Hamish S, Liu, Paul P, Godley, Lucy A, Brown, Anna L
Published in Blood advances (05.07.2023)
Get full text
Published in Blood advances (05.07.2023)
Journal Article
Haemopoietic Improvement Following Iron Chelation for Transfusional Haemosiderosis in Patients with Haematopoietic Neoplasia and Aplastic Anaemia: An Observational Study
Opat, Stephen, Bird, Robert, Forsyth, Cecily J, Szer, Jeffrey, Tam, Constantine S., Motum, Penelope, Bentley, Mark A.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
A Randomised Dose De-Escalation Study of Oral Fludarabine, ±Oral Cyclophosphamide and Intravenous Rituximab As First-Line Therapy of Fit Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years: Final Analysis of Response and Toxicity
Mulligan, Stephen P., Gill, Devinder, Turner, Paul, Renwick, William E.P., Latimer, Maya, Mackinlay, Naomi, Berkahn, Leanne, Simpson, David, Campbell, Philip, Forsyth, Cecily J, Cull, Gavin, Harrup, Rosemary, Sulda, Melanie, Best, Giles, Bressel, Mathias, Di Iulio, Juliana, Kuss, Bryone J
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Toxicity Is Not Associated with Age or Comorbidity Score in a Randomised Study of Oral Fludarabine and Cyclophosphamide and IV Rituximab (FCR) As First-Line Therapy of Fit, Elderly Patients with Chronic Lymphocytic Leukemia (CLL)
Mulligan, Stephen P., Gill, Devinder, Turner, Paul, Renwick, William E.P., Latimer, Maya, Mackinlay, Naomi, Berkahn, Leanne, Simpson, David R, Campbell, Philip, Forsyth, Cecily J, Cull, Gavin, Harrup, Rosemary, Sulda, Melanie, Best, Giles, Bressel, Mathias, Di Iulio, Juliana, Kuss, Bryone J
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Early Switch to Nilotinib Does Not Overcome the Adverse Outcome for CML Patients Failing to Achieve Early Molecular Response On Imatinib, Despite Excellent Overall Outcomes in the TIDEL II Trial
Yeung, David T, Osborn, Michael Philip, White, Deborah L, Branford, Susan, Kornhauser, Michael, Slader, Cassandra, Issa, Samar, Hiwase, Devendra K., Hertzberg, Mark S., Schwarer, Anthony P., Filshie, Robin, Arthur, Christopher K, Kwan, Yiu Lam, Forsyth, Cecily J, Ross, David, Mills, Anthony K., Grigg, Andrew, Hughes, Timothy P.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Immunoglobulin G (IgG) Subclasses in Chronic Lymphocytic Leukaemia
Freeman, Jane A., Forsyth, Cecily J., Mackinlay, Naomi J., Han, Ping, Mulligan, Stephen P.
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Upfront Imatinib Therapy in CML Patients with Rapid Switching to Nilotinib for Failure to Achieve Molecular Targets or Intolerance Achieves High Overall Rates of Molecular Response and a Low Risk of Progression - An Update of the TIDEL-II Trial
Yeung, David T., Osborn, Michael, White, Deborah L., Branford, Susan, Kornhauser, Michael, Slader, Cassandra, Issa, Samar, Hiwase, Devendra K, Hertzberg, Mark S., Schwarer, Anthony P., Filshie, Robin, Arthur, Christopher K, Kwan, Yiu Lam, Forsyth, Cecily J, Ross, David, Mills, Anthony K., Grigg, Andrew, Hughes, Timothy P.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Enzastaurin in Patients with Non-Hodgkin Lymphomas: A Multicenter, Open-Label, Screening Study
Forsyth, Cecily J., Gomez, David, Eliadis, Paul, Crespo-Solis, Erick, Pereira, Juliana, Roberson, Stephanie, Anderson, Deborah, Hamid, Oday, Smith, Neil V
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
Selective Escalation of Imatinib Therapy and Early Switching to Nilotinib In De Novo Chronic Phase CML Patients: Interim Results From the TIDEL-II Trial
Yeung, David T., Osborn, Michael, White, Deborah L., Branford, Susan, Haswell, Lauren, Slader, Cassandra, Issa, Samar, Hiwase, Devendra K., Hertzberg, Mark S., Schwarer, Anthony P., Filshie, Robin, Arthur, Christopher K., Kwan, Yiu Lam, Forsyth, Cecily J., Ross, David M., Mills, Anthony K., Grigg, Andrew, Hughes, Timothy, ALLG, on Behalf Of
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article